Crescita Therapeutics (TSE:CTX) Reaches New 52-Week High – Time to Buy?

Shares of Crescita Therapeutics Inc. (TSE:CTX) reached a new 52-week high on Monday . The company traded as high as C$0.76 and last traded at C$0.76, with a volume of 9067 shares trading hands. The stock had previously closed at C$0.76.

Crescita Therapeutics Stock Performance

The company has a quick ratio of 2.29, a current ratio of 2.80 and a debt-to-equity ratio of 17.34. The stock has a 50 day simple moving average of C$0.70 and a two-hundred day simple moving average of C$0.55. The stock has a market capitalization of C$14.15 million, a P/E ratio of 37.50 and a beta of -1.34.

Crescita Therapeutics (TSE:CTX) last posted its quarterly earnings results on Monday, May 11th. The company reported C($0.06) earnings per share for the quarter. The company had revenue of C$5.64 million during the quarter. Crescita Therapeutics had a negative net margin of 1.38% and a negative return on equity of 2.07%.

About Crescita Therapeutics

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.